We began to research for this book in 2000, with the idea that we might contribute to the search for solutions to the global HIV/AIDS pandemic by c- bining perspectives from different disciplines. Much has happened in the interv- ing years. First, the severity of the HIV/AIDS pandemic in sub-Saharan Africa - and the threat it posed for many others regions of the world - led to a movement among several countries to correct the imbalance between producers and users of ph- maceutical products. This effort produced a clarification of the right of gove- ments to produce generic medicine under compulsory licenses and an amendment of the World Trade Organization's TRIPS Agreement to allow exports of generic medicines from one WTO Member to another. In 2007, the amended rules were put into practice, with Canada authorizing the export of generic antiretroviral drugs to Rwanda. However, at the same time, global patent laws have been undermined due to regulatory capture, most notably in free trade agreements and through political pressure on countries like Thailand to not to exercise their right to issue compulsory licenses for pharmaceutical products. Second, the amount of money available for the treatment and prevention of HIV/AIDS has increased dramatically, with the establishment of the World Bank Multi-Country HIV/AIDS Program for Africa (MAP), the Global Fund to Fight AIDS, Tuberculosis and Malaria and the US President's Emergency Plan for AIDS Relief (PEPFAR), among other funding initiatives.

We began to research for this book in 2000, with the idea that we might contribute to the search for solutions to the global HIV/AIDS pandemic by c- bining perspectives from different disciplines. Much has happened in the interv- ing years. First, the severity of the HIV/AIDS pandemic in sub-Saharan Africa - and the threat it posed for many others regions of the world - led to a movement among several countries to correct the imbalance between producers and users of ph- maceutical products. This effort produced a clarification of the right of gove- ments to produce generic medicine under compulsory licenses and an amendment of the World Trade Organization's TRIPS Agreement to allow exports of generic medicines from one WTO Member to another. In 2007, the amended rules were put into practice, with Canada authorizing the export of generic antiretroviral drugs to Rwanda. However, at the same time, global patent laws have been undermined due to regulatory capture, most notably in free trade agreements and through political pressure on countries like Thailand to not to exercise their right to issue compulsory licenses for pharmaceutical products. Second, the amount of money available for the treatment and prevention of HIV/AIDS has increased dramatically, with the establishment of the World Bank Multi-Country HIV/AIDS Program for Africa (MAP), the Global Fund to Fight AIDS, Tuberculosis and Malaria and the US President's Emergency Plan for AIDS Relief (PEPFAR), among other funding initiatives.

Trade Law The intersection of insurance regulation and trade agreements is of obvious significance to international competitiveness and, thereby, to national welfare. Yet until this masterful study the subject has remained virtually unexplored. Insurance Regulation in North America, far from merely addressing this important area of theory and practice, superbly balances a world of detailed analysis and commentary with deeply insightful interpretation and debate. The book's focus on insurance regulation in three countries allows the authors to approach the subject in an extraordinary depth that could not be achieved in a more global account. In the course of their treatment the authors offer the reader the following invaluable insights, among many others: analysis of the political dimension of reaching agreements and of implementing them; comparison of the three major trade agreements that apply in the North American insurance market - NAFTA, WTO agreements on financial services, and MEUFTA (the Mexico-European Union Free Trade Agreement) - with emphasis on the relationship between GATS and NAFTA principles; investigation of the clear convergence of regulatory schemes and the probable limits to harmonization; discussion of the arbitrage by which companies get around regulatory restrictions and exploit opportunities created by loopholes; clarification of the crucial issues surrounding the role of customary international law principles in investor protection obligations; discussion of the level of government and which government agencies a company must turn to in order to satisfy legal requirements; analysis of the jurisprudence of the Supreme Court of Mexico regarding legal effects of treaties on domestic law; commentary on the effects of demutualization and of mergers and acquisitions discussion of the effect of the entrenchment of U.S. State regulations and the federal government's lack of clear power to force State compliance; and description of dispute settlement procedures between governments. Although important issues arising in each of the three countries are all covered, there is an emphasis on the Mexican market in recognition of Mexico's greater future growth potential and of the relative paucity of relevant literature in English. Major case studies that reveal processes of compliance or conflict are analyzed in detail. For insurance professionals - lawyers, business executives, and policymakers - who want to understand what international trade agreements contain, how they work, and how they affect domestic insurance regulation and business strategy in what is rapidly becoming a global market for insurance and other financial services, this book is a gold mine. Scholars and academics in insurance law and international economic law will also find here a fresh new treatise of great significance.

Condon explains key aspects of NAFTA and WTO rules on trade in goods and services, foreign direct investment and intellectual property protection and shows how these rules affect global business strategies. Cases are used to illustrate how these agreements work and how they affect crucial business interests. He examines the political context in which the negotiation and enforcement of trade agreements take place and how business people can enforce the rules and influence the negotiations to support global business strategies. He also shows how NAFTA, WTO, and global business strategy affect some of the major issues of our time, such as AIDS, global security, environmental protection, globalization protesters, and illegal migration from Mexico to the United States.

Anyone doing business from, to, and within the NAFTA region will find this essential reading. NAFTA and WTO interact in ways that can make or break a company's strategy. Business strategists must consider the impact of today's rules and how future developments will affect them. However, as Condon makes clear, this book is about more than just business. The globalization of law and business affects the lives of everyone. Scholars, researchers, students, and international business professionals will find the book of value, as will those involved with financial services, international law, and international relations.